Retifer 210 Tablet

About Retifer 210 1000 mg Tablet

The tablet Retifer 210 contains Ferric Citrate and is made by Opsonin Pharma Limited. In people on dialysis, it helps control serum phosphorus levels by binding phosphate in the gut.

There are 4 brands of Ferric Citrate listed in Bangladesh. The lowest listed price is Revocit 1000 mg Tablet at ৳ 25.00 per unit.

What is Retifer 210 1000 mg Tablet?

The tablet Retifer 210 contains Ferric Citrate and is made by Opsonin Pharma Limited. The dose is decided by the doctor based on individual needs and monitoring. Ferric Citrate works by binding phosphate in the gut and by providing iron that the body can absorb. The doctor decides the dose and course.

Uses of Retifer 210

In people on dialysis, it helps control serum phosphorus levels by binding phosphate in the gut. The doctor determines whether this medicine is appropriate based on the patient's condition and test results. It is not for use in people with iron overload syndromes. Your doctor will decide if it is suitable for you.

How to use Retifer 210

If a dose is missed, ask the doctor or pharmacist what to do. Retifer 210 is taken by mouth. Swallow the tablet with water. Complete the course exactly as prescribed. Follow the doctor's instructions carefully and attend regular check-ups.

Side effects of Retifer 210

Some people may notice changes in iron stores, so the doctor may check iron parameters. Common side effects of Retifer 210 1000 mg tablet include discolored feces, diarrhea, constipation, nausea, vomiting, cough, abdominal pain, and high potassium levels (hyperkalemia). Contact your doctor if you notice anything unusual after taking it. Do not stop or change the medicine on your own without medical advice.

Safety and precautions

There are no available data on use in pregnancy or breastfeeding, so pregnant or breastfeeding women should ask a doctor first. Retifer 210 is not for people with iron overload syndromes. Your doctor will check iron levels before and during treatment because iron absorption may lead to excessive iron stores.

Frequently asked questions

What does Retifer 210 treat?

In people on dialysis, it helps control serum phosphorus levels by binding phosphate in the gut. The doctor determines whether this medicine is appropriate based on the patient's condition and test results.

How do I use Retifer 210 correctly?

If a dose is missed, ask the doctor or pharmacist what to do. Retifer 210 is taken by mouth.

What are the side effects of Retifer 210?

Some people may notice changes in iron stores, so the doctor may check iron parameters. Common side effects of Retifer 210 1000 mg tablet include discolored feces, diarrhea, constipation, nausea, vomiting, cough, abdominal pain, and high potassium levels (hyperkalemia).

Can I use Retifer 210 in pregnancy or while breastfeeding?

There are no available data on use in pregnancy or breastfeeding, so pregnant or breastfeeding women should ask a doctor first. Retifer 210 is not for people with iron overload syndromes.

Indications

Ferric Citrate is a phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. Ferric Citrate is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis.

Pharmacology

Hyperphosphatemia in chronic kidney disease on dialysis: Ferric iron binds dietary phosphate in the GI tract and precipitates as ferric phosphate. This compound is insoluble and is excreted in the stool. By binding phosphate in the GI tract and decreasing absorption, ferric citrate lowers the phosphate concentration in the serum.

Iron deficiency anemia in chronic kidney disease not on dialysis: Ferric iron is reduced from the ferric to the ferrous form by ferric reductase in the GI tract. After transport through the enterocytes into the blood, oxidized ferric iron circulates bound to the plasma protein transferrin, and can be incorporated into hemoglobin.

Dosage & Administration

Hyperphosphatemia in chronic kidney disease on dialysis:
  • Starting dose is 2 tablets orally 3 times per day with meals.
  • Adjust dose by 1 to 2 tablets as needed to maintain serumphosphorus at target levels, up to a maximum of 12 tablets daily. Dose can be titrated at 1-week or longer intervals.
Iron deficiency anemia in chronic kidney disease not on dialysis:
  • Starting dose is 1 tablet orally 3 times per day with meals.
  • Adjust dose as needed to achieve and maintain hemoglobin goal, up to a maximum of 12 tablets daily.

Interaction

When clinically significant drug interactions are expected, consider separation of the timing of administration. Consider monitoring clinical responses or blood levels of the concomitant medication.

Contraindications

Ferric Citrate is contraindicated in patients with iron overload syndromes.

Side Effects

Most common adverse reactions (incidence ≥5%) are discolored feces, diarrhea, constipation, nausea, vomiting, cough, abdominal pain, and hyperkalemia.

Pregnancy & Lactation

There are no available data on Ferric Citrate use in pregnant women to inform a drug-associated risk of major birth defects and miscarriage. There are no human data regarding the effect of Ferric Citrate in human milk, the effects on the breastfed child, or the effects on milk production.

Precautions & Warnings

Iron absorption from Ferric Citrate may lead to excessive elevations in iron stores. Increases in serum ferritin and transferrin saturation (TSAT) levels were observed in clinical trials. In a 56-week safety and efficacy trial evaluating the control of serum phosphate levels in patients with chronic kidney disease on dialysis in which concomitant use of intravenous iron was permitted, 55 (19%) of patients treated with Ferric Citrate had a ferritin level >1500 ng/mL as compared with 13 (9%) of patients treated with active control. Assess iron parameters (e.g., serum ferritin and TSAT) prior to initiating Ferric Citrate and monitor iron parameters while on therapy. Patients receiving intravenous iron may require a reduction in dose or discontinuation of intravenous iron therapy.

Overdose Effects

No data are available regarding overdose of Ferric Citrate in patients. In patients with chronic kidney disease, the maximum dose studied was 2,520 mg ferric iron (12 tablets of Ferric Citrate) per day. Iron absorption from Ferric Citrate may lead to excessive elevations in iron stores, especially when concomitant intravenous iron is used.

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Ferric Citrate

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.